Lexicon Pharmaceuticals, Inc.
LXRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001062822
No open-market purchases or sales by Lexicon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 149 institutions reported holding it in 13F filings for Q2 2026, worth $875.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Lexicon Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 107 | 1 | 107 | +1 |
| Shares | 121.2M | 4.32M | 117.7M | +789.3K (+0.7%) |
| Value | $711.5M | $25.4M | $540.2M | −$146.0M (−21.3%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (22)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Acadian Asset Management LLC | 462,296 | $2.71M |
| Skandinaviska Enskilda Banken AB (publ) | 179,800 | $1.05M |
| Nisa Investment Advisors, LLC | 140,000 | $822.0K |
| Campbell & CO Investment Adviser LLC | 103,100 | $605.0K |
| California Public Employees Retirement System | 84,600 | $497.0K |
| Vestmark Advisory Solutions, Inc. | 42,418 | $249.0K |
| NewEdge Wealth, LLC | 42,418 | $249.0K |
| Engineers Gate Manager LP | 33,221 | $195.0K |
| Caxton Associates LP | 28,705 | $168.0K |
| Athanor Capital, LP | 20,713 | $122.0K |
| Cetera Investment Advisers | 20,689 | $121.0K |
| Qube Research & Technologies Ltd | 20,490 | $120.0K |
| Dynamic Technology Lab Private Ltd | 19,084 | $112.0K |
| Walleye Capital LLC | 17,400 | $102.0K |
| XTX Topco Ltd | 14,165 | $83.0K |
| Cubist Systematic Strategies, LLC | 12,943 | $76.0K |
| WMS Partners, LLC | 11,200 | $66.0K |
| Zacks Investment Management | 11,011 | $65.0K |
| HighTower Advisors, LLC | 10,903 | $64.0K |
| Bank of Montreal | 1,450 | $8.00K |
| International Assets Investment Management, LLC | 785 | $3.00K |
| Point72 Hong Kong Ltd | 57 | $0 |
Not filed for Q2 2021 yet (1)
Institutions that held Lexicon Pharmaceuticals, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25.4M |